A detailed history of Beacon Pointe Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 20,726 shares of DXCM stock, worth $1.55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
20,726
Previous 23,475 11.71%
Holding current value
$1.55 Million
Previous $2.66 Million 47.8%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $175,936 - $319,048
-2,749 Reduced 11.71%
20,726 $1.39 Million
Q2 2024

Aug 12, 2024

SELL
$110.31 - $140.45 $19,083 - $24,297
-173 Reduced 0.73%
23,475 $2.66 Million
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $29,582 - $36,285
-259 Reduced 1.08%
23,648 $3.28 Million
Q4 2023

Feb 08, 2024

SELL
$75.49 - $124.16 $78,660 - $129,374
-1,042 Reduced 4.18%
23,907 $2.97 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $62,909 - $100,826
731 Added 3.02%
24,949 $2.33 Million
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $8,097 - $9,430
-72 Reduced 0.3%
24,218 $3.11 Million
Q1 2023

May 12, 2023

BUY
$104.0 - $122.92 $520 - $614
5 Added 0.02%
24,290 $2.82 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $114,383 - $165,113
1,346 Added 5.87%
24,285 $2.75 Million
Q3 2022

Nov 09, 2022

BUY
$76.35 - $94.18 $27,485 - $33,904
360 Added 1.59%
22,939 $1.85 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $1.14 Million - $2.23 Million
16,790 Added 290.03%
22,579 $1.69 Million
Q1 2022

May 17, 2022

BUY
$94.08 - $130.2 $46,381 - $64,188
493 Added 9.31%
5,789 $2.96 Million
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $118,831 - $148,980
-915 Reduced 14.73%
5,296 $2.84 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $440,178 - $590,617
4,125 Added 197.75%
6,211 $3.4 Million
Q2 2021

Aug 17, 2021

BUY
$80.99 - $107.93 $168,945 - $225,141
2,086 New
2,086 $891,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.